Back
Open Access

Changes in global myocardial work indices during mavacamten treatment in obstructive hypertrophic cardiomyopathy

Session: ePosters in myocardial disease - hypertrophic cardiomyopathy (2)
Topic: Hypertrophic Cardiomyopathy
Speaker: Doctor R. Sepp (Szeged, HU)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Robert Sepp

University of Szeged, Szeged (Hungary)
3 presentations
0 follower

7 more presentations in this session

Recognizing red flags: don't judge a book by its cover. data from a multicentric nationwide study

Speaker: Doctor A. Pinho (Porto, PT)

Access
Abstract
Like
Thumbnail

Mavacamten use in a real-world cohort of obstructive hypertrophic cardiomyopathy patients: insights from the initial centre experience

Speaker: Doctor M. Lima (Lisbon, PT)

Access
Abstract
Like
Thumbnail

Estimating hypertrophic cardiomyopathy genotype pre-test probability: an online calculator

Speaker: Mr P. Kopp (Stony Brook, US)

Access
Abstract
Like
Thumbnail

Differentiating clinical trial endpoints in transthyretin cardiac amyloidosis is significantly improved with continuing medical education

Speaker: Doctor C. Rohani-Montez (London, GB)

Access
Abstract
Like
Thumbnail

Effect of TTR stabilisers on strain values derived by echocardiography in patients with wild type ATTR Amyloidosis

Speaker: Doctor J. Westphal (Jena, DE)

Access
Abstract
Like
Thumbnail

Access the full session

ePosters in myocardial disease - hypertrophic cardiomyopathy (2)

Speakers: Doctor R. Sepp, Doctor A. Pinho, Doctor M. Lima, Mr P. Kopp, Doctor C. Rohani-Montez...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources